Irritable bowel disease is very common colon disease. Deflazacort is one of the best drug with clinical activity against Irritable bowel disease. Microsphere system are effectively protect drugs against premature degradation, to localize drug molecules at the target site of action and to control the time and rate of release. Mucoadhesive microspheres enhance the bioavailability of orally given drugs by lengthened contact time of drug with the intestinal mucosa. The main disadvantage of these microspheres is adherence to the substrate by non-specific interaction. To overcome this limitation, microspheres are prepared by emulsification method to treat irritable bowel disease. Chitosan microspheres were prepared by Ionotropic Gelation method. Microspheres were coated with Eudragil S using solvent evaporation method.
INTRODUCTION
Colon was considered as a part of body solely responsible for absorption of water, electrolyte and temporary storage of stools, but now it is accepted as an important site for drug delivery. Targeted delivery ensures the direct treatment at the disease site, lower dosing, and minimizing side effects. Drug targeting to colon is highly desirable for local treatment of a variety of bowel diseases. Moreover, dosage forms with mucoadhesive properties may prolong the residence time at the site of drug absorption. Mucoadhesive microparticulates coated with a pH-dependent polymer are proposed to initiate the release of the drug at the putative colonic pH 7-8. [1] [2] [3] Deflazacort is a drug of choice in Ulcerative colitis with proven anti inflammatory and immunosuppressive effect. Deflazacort is a corticosteroid that works by acting within cells to prevent the release of certain chemicals that are important in the immune system. These chemicals are involved in producing immune and allergic responses, resulting in inflammation by decreasing the release of these chemicals in a particular area, inflammation is reduced. Deflazacort has a shorter biological half life of 1.1-1.9 hr. Thus by using deflazacort microspheres half life is increased and provide sustained release of drug for longer duration and thus bioavailability problems associated with oral administration is also improved and microspheres with mucoadhesive properties may prolong the residence time at the site of drug absorption. [3] [4] 
MATERIAL AND METHODS

Material
Deflazacort was collected as a gift sample from Alcon bio sciences PVT Ltd, Mumbai. Eudragit-S 100 obtained from Degussa India Pvt Ltd. Sodium Alginate and chitosan were received from Loba Chemie Pvt. Ltd (Mumbai, India). All other reagents and chemicals used were of analytical grade.
Methods
Preparation of mucoadhesive microsphere of Deflazacort
Chitosan microspheres were prepared by ionotropic gelation method.
Preparation I: Chitosan stock solution (1% w/v) was prepared by dissolving chitosan in acetic acid (1% v/v) at room temperature.
Preparation II:
The drug and sodium alginate was dissolved in 100 ml of water.
Preparation III: 1% Sodium tripolyphosphate solution was prepared.
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Preparation II was added in preparation IV through a disposable syringe needle into a gently agitating. The dropping rate and falling distance were kept constant. The solution was magnetically stirred for half an hour followed by filtration and rinsing with distilled water. Gel like beads were obtained which was air dried for twenty four hours followed by oven drying for six hours at 40˚C. [5] [6] 
Coating of mucoadhasive microspheres
Microspheres were coated with Eudragil S (ES) using solvent evaporation method. mucoadhasive microspheres (50 mg) were dispersed in 10 mL of coating solution prepared by dissolution of 500 mg of ES in ethanol:acetone (2:1) to give 5:1 (coat:core ratio). This organic phase was then poured in 70 mL of light liquid paraffin containing 1% wt/vol Span 80. The system was maintained under agitation speed of 1000 rpm at room temperature for 3 hours to allow for the evaporation of solvent. Finally, the coated microsphere were filtered, washed with n-hexane, and dried in desiccator. [7] [8] Evaluation of microspheres
Percentage Yield
The prepared microspheres with a size range of 200-300nm were collected and weighed from different formulations. The measured weight was divided by the total amount of all nonvolatile components which were used for the preparation of the microspheres. [5] [6] 
Drug Entrapment
The various formulations of the mucoadhasive microspheres were subjected for drug content. 10 mg of mucoadhasive microspheres from all batches were accurately weighed and crushed. The powder of microspheres were dissolved in 10 ml 7.4 pH Phosphate Buffer and centrifuge at 1000 rpm. This supernatant solution is than filtered through whatmann filter paper No. 44. After filtration, from this solution 0.1 ml was taken out and diluted up to 10 ml with 7.4 pH Phosphate Buffer. The percentage drug entrapment was calculated using calibration curve method. [7] [8] 
In-vitro wash off test
The mucoadhesive property of microspheres was evaluated by an in vitro adhesion testing method known as the washoff test. Freshly excised pieces of intestinal mucosa from sheep were mounted onto glass slide. About 100 microspheres were spread onto wet rinsed tissue specimen and immediately thereafter the slides were hung onto the arm of a tablet disintegrating machine. Then the machine was operated. The tissue specimen was given a slow, regular up and down movement in the test fluid at about 37°C contained in a vessel of the machine. At the end of 1, 2, 3, 4, 5, 6, 7,8 hrs the machine was stopped and the number of microspheres still adhering to the tissue was counted. The test was performed at 0.1N hydrochloric acid solution.
% Mucoadhesion = (Na-Nl) / Na × 100
Where, Na = number of microspheres applied; Nl = number of microspheres leached out. 9-10
Measurement of mean particle size
The mean size of the microspheres was determined by Photo Correlation Spectroscopy (PCS) on a submicron particle size analyzer at a scattering angle of 90°. A sample (0.5mg) of the microspheres suspended in 5 ml of distilled water was used for the measurement. 11
Determination of zeta potential
The zeta potential of the drug-loaded microspheres was measured on a zeta sizer by determining the electrophoretic mobility in a micro electrophoresis flow cell. All the samples were measured in water at 25°C in triplicate. [9] [10] [11] 
Shape and Surface Characterization of Microspheres by Scanning Electron Microscopy (SEM)
From the formulated batches of microspheres, formulations (F3) which showed an appropriate balance between the percentage releases were examined for surface morphology and shape using scanning electron microscope Jeol Japan 6000. Sample was fixed on carbon tape and fine gold sputtering was applied in a high vacuum evaporator. The acceleration voltage was set at 10KV during scanning. Microphotographs were taken on different magnification and higher magnification (200X) was used for surface morphology. [10] [11] [12] In-vitro Release Studies
In vitro drug release in gastrointestinal fluids of different pH
The prepared microsphere was evaluated for in vitro drug release. The drug release studies were carried out using USP XXII paddle type Dissolution test apparatus. The dissolution study was carried out in 900 ml dissolution medium which was stirred at 100 rpm maintained at 37±0.2C. The scheme of using the simulated fluids at different timing was as follows: 
RESULTS AND DISCUSSION
Evaluation of deflazacort microspheres Percentage Yield
Percentage yield of different formulation was determined by weighing the Microspheres after drying. The percentage yield of different formulation was in range of 82.56 -93.58%. 
Drug Entrapment
The drug entrapment of different formulations was in range of 78.05-83.25% w/w. This is due to the permeation characteristics of HPMC that could facilitate the diffusion of part of entrapped drug to surrounding medium during preparation of deflazacort microspheres. The maximum Percentage Yield, Drug Entrapment was found to be formulation F3. The optimized formulation of batches subjected to further studies. 
Results of In-vitro wash off test
Particle size analysis
The mean size of the microspheres was determined by photo correlation spectroscopy (PCS) on a submicron particle size analyzer (Horiba Instruments) at a scattering angle of 90°. A sample (0.5mg) of the microspheres suspended in 5 ml of distilled water was used for the measurement. The results of measurement of mean particle size of optimized formulation F3 microsphere was found 150.9 nm respectively. 
Zeta Potential
The zeta potential of the drug-loaded microspheres was measured on a zeta sizer (Malvern Instruments) by determining the electrophoretic mobility in a micro electrophoresis flow cell. All the samples were measured in water at 25°C in triplicate. Results of zeta potential of optimized formulation F3 microsphere was found -10.7 mV respectively. 
Stability studies
Stability studies were carried out with optimized formulation which was stored for a period of 45 days at 4±1°C, RT and 40±1°C. The particle size of formulation was determined by optical microscopy using a calibrated ocular micrometer. The particle size of the microsphere was found to increase at RT, which may be attributed to the aggregation of microsphere at higher temperature. At 452°C the microsphere aggregate i.e. these microsphere were unstable at higher temperature like 452°C. Percent efficiency of mucoadhesive Microspheres also decrease at higher temperature Like 452°C.
CONCLUSION
From the result of present study, it can be concluded that chitosan based deflazacort mucoadhesive microspheres offer a high degree of protection from premature drug release in simulated upper GIT conditions and deliver most of the drug load in the colon and allow drug release to occur at the desired site. Based on the results of the physicochemical characterization and in vitro drug release studies, it possessed all the required physicochemical characters and with drug releases up to 12 h where it released 67.8 % of the deflazacort. Thus, chitosan based microspheres are a potential system for colon delivery of deflazacort for Ulcerative colitis.
